A Study to Assess the Effects of Age and Gender on the Pharmacokinetics of JNJ-42847922 in Healthy Adults

NCT02837692 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-42847922 10 milligram (mg)
DRUG: JNJ-42847922 20 mg
DRUG: JNJ-42847922 40 mg
DRUG: JNJ-42847922 60 or 80 mg

Sponsor

Janssen Research & Development, LLC